Based on our previous finding that the loss of AMPK activation was a frequent event in pancreatic cancer (Duan et al., 2017), in the present study, we hypothesized that AMPK inactivation promotes the amplification and abnormal activation of the tumor‐promoting HSF1, thus promoting pancreatic cancer progression. The gene discussed is HSF1; the disease is pancreatic neoplasm.